Hypertension Diagnostics, Inc. designs, develops, manufactures, and markets proprietary noninvasive medical devices that detect subtle changes in the elasticity of arteries. The company was founded by Jay N. Cohn and Stanley M. Finkelstein on July 19, 1988 and is headquartered in Minneapolis, MN.
Company profile
Ticker
HDII
Exchange
Website
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
IRS number
411618036
HDII stock data
Latest filings (excl ownership)
UPLOAD
Letter from SEC
28 Feb 20
CORRESP
Correspondence with SEC
13 Feb 20
CORRESP
Correspondence with SEC
5 Feb 20
RW
Registration withdrawal request
17 Jan 20
UPLOAD
Letter from SEC
17 Dec 19
10-Q
2019 Q3
Quarterly report
14 Nov 19
10-Q
2019 Q2
Quarterly report
19 Sep 19
10-Q
2019 Q1
Quarterly report
19 Sep 19
10-K
2018 FY
Annual report
18 Sep 19
10-K
2017 FY
Annual report
18 Sep 19
Latest ownership filings
SC 13D
BRIMMER KENNETH WILLIAM
21 Feb 12
SC 13D
COHN JAY N MD
11 Feb 11
SC 13D
STERN ALAN
11 Feb 11
SC 13D
LEITNER LARRY
11 Feb 11
144
Notice of proposed sale of securities
24 Feb 04
144
Notice of proposed sale of securities
17 Nov 03
144
Notice of proposed sale of securities
13 Aug 03
144
Notice of proposed sale of securities
24 Apr 03
Institutional ownership, Q3 2021
0.0% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 1 |
Opened positions | 1 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 1.00 k |
Total shares | 30.00 k |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Triumph Capital Management | 30.00 k | $1.00 k |